Abstract
The phytochemical resveratrol has been reported to induce NQO1, an enzyme involved in detoxification reactions, by as yet undetermined mechanisms. Using K562 cells as a model, we showed that 25-50 μM resveratrol increased NQO1 that peaked at 24-48 h. A 2.5-fold rise in NQO1 protein levels was accompanied by a comparable elevation in mRNA copy number and a 3- to 5-fold increase in NQO1 enzymatic activity. Fluorescent microscopic analysis in combination with transfection experiments with plasmids harboring different segments of the 5-flanking region of NQO1 gene linked to a reporter provided evidence that the modulation of NQO1 gene expression by resveratrol involved the antioxidant response element ARE, accompanied by an increase in the state of phosphorylation of transcription factor Nrf2 and its re-distribution to the nucleus. This change in cellular localization of Nrf2 may be linked to resveratrol-elicited disruption of the Nrf2-Keap1 complex in the cytosol, followed by the translocation of Nrf2 to the nucleus where it locates the ARE-containing 5-promoter region of NQO1 leading to its transcriptional activation.
Keywords: response element ARE, antioxidant, transcriptional factor Nrf2, transcriptional control, K562 cells, quinone reductase 1, Resveratrol
Medicinal Chemistry
Title: Induction of Quinone Reductase NQO1 by Resveratrol in Human K562 Cells Involves the Antioxidant Response Element ARE and is Accompanied by Nuclear Translocation of Transcription Factor Nrf2
Volume: 2 Issue: 3
Author(s): Joseph M. Wu, Tze-chen Hsieh, Xiaohua Lu and Zhirong Wang
Affiliation:
Keywords: response element ARE, antioxidant, transcriptional factor Nrf2, transcriptional control, K562 cells, quinone reductase 1, Resveratrol
Abstract: The phytochemical resveratrol has been reported to induce NQO1, an enzyme involved in detoxification reactions, by as yet undetermined mechanisms. Using K562 cells as a model, we showed that 25-50 μM resveratrol increased NQO1 that peaked at 24-48 h. A 2.5-fold rise in NQO1 protein levels was accompanied by a comparable elevation in mRNA copy number and a 3- to 5-fold increase in NQO1 enzymatic activity. Fluorescent microscopic analysis in combination with transfection experiments with plasmids harboring different segments of the 5-flanking region of NQO1 gene linked to a reporter provided evidence that the modulation of NQO1 gene expression by resveratrol involved the antioxidant response element ARE, accompanied by an increase in the state of phosphorylation of transcription factor Nrf2 and its re-distribution to the nucleus. This change in cellular localization of Nrf2 may be linked to resveratrol-elicited disruption of the Nrf2-Keap1 complex in the cytosol, followed by the translocation of Nrf2 to the nucleus where it locates the ARE-containing 5-promoter region of NQO1 leading to its transcriptional activation.
Export Options
About this article
Cite this article as:
Wu M. Joseph, Hsieh Tze-chen, Lu Xiaohua and Wang Zhirong, Induction of Quinone Reductase NQO1 by Resveratrol in Human K562 Cells Involves the Antioxidant Response Element ARE and is Accompanied by Nuclear Translocation of Transcription Factor Nrf2, Medicinal Chemistry 2006; 2 (3) . https://dx.doi.org/10.2174/157340606776930709
DOI https://dx.doi.org/10.2174/157340606776930709 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Role of Oxidative-Nitrosative Stress and Downstream Pathways in Various Forms of Cardiomyopathy and Heart Failure
Current Vascular Pharmacology Does in vitro Fertilisation Increase Type 2 Diabetes and Cardiovascular Risk?
Current Diabetes Reviews Von Willebrand Factor: Drug and Drug Target
Cardiovascular & Hematological Disorders-Drug Targets Identification of Candidate Biomarkers of Acute Aortic Dissection
Recent Patents on DNA & Gene Sequences Metabolic Reprogramming of Human Cells in Response to Oxidative Stress: Implications in the Pathophysiology and Therapy of Mitochondrial Diseases
Current Pharmaceutical Design Direct Somatic Cell Reprogramming: Treatment of Cardiac Diseases
Current Gene Therapy Modulation of Cardiac Metabolism During Myocardial Ischemia
Current Pharmaceutical Design Sterol Biosynthesis Pathway as an Alternative for the Anti-Protozoan Parasite Chemotherapy
Current Medicinal Chemistry Ghrelin in Obesity, Physiological and Pharmacological Considerations
Mini-Reviews in Medicinal Chemistry Biomarkers of Atrial Fibrillation in Hypertension
Current Medicinal Chemistry Recent Advances in the Management of Pulmonary Arterial Hypertension
Current Respiratory Medicine Reviews Nutrition in Infancy
Current Pediatric Reviews Pathophysiology of Platelet Resistance to Anti-Aggregating Agents in Insulin Resistance and Type 2 Diabetes: Implications for Anti-Aggregating Therapy
Cardiovascular & Hematological Agents in Medicinal Chemistry Twin-to-Twin Transfusion Syndrome: From Placental Anastomoses to Long-Term Neurodevelopmental Outcome
Current Pediatric Reviews PPARs and Diabetes-Associated Atherosclerosis
Current Pharmaceutical Design Oxidative Stress Modulation Through Habitual Physical Activity
Current Pharmaceutical Design Glucose Sensors Based on Core@Shell Magnetic Nanomaterials and Their Application in Diabetes Management: A Review
Current Pharmaceutical Design Prevention of Macrovascular Disease in Type 2 Diabetic Patients: Blockade of the Renin-Angiotensin-Aldosterone System
Current Diabetes Reviews Pharmaceutical Care: Past, Present and Future
Current Pharmaceutical Design Capsaicin Sensitive-Sensory Nerves and Blood Pressure Regulation
Current Medicinal Chemistry - Cardiovascular & Hematological Agents